148 related articles for article (PubMed ID: 3297965)
1. Inappropriate secretion of thyrotropin by the pituitary.
Faglia G; Beck-Peccoz P; Piscitelli G; Medri G
Horm Res; 1987; 26(1-4):79-99. PubMed ID: 3297965
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995.
Beck-Peccoz P; Mariotti S; Guillausseau PJ; Medri G; Piscitelli G; Bertoli A; Barbarino A; Rondena M; Chanson P; Pinchera A
J Clin Endocrinol Metab; 1989 Jan; 68(1):208-14. PubMed ID: 2491862
[TBL] [Abstract][Full Text] [Related]
3. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST.
Beck-Peccoz P; Roncoroni R; Mariotti S; Medri G; Marcocci C; Brabant G; Forloni F; Pinchera A; Faglia G
J Clin Endocrinol Metab; 1990 Jul; 71(1):19-25. PubMed ID: 2370293
[TBL] [Abstract][Full Text] [Related]
4. Treatment of inappropriate secretion of thyrotropin with somatostatin analog SMS 201-995.
Beck-Peccoz P; Medri G; Piscitelli G; Mariotti S; Bertoli A; Barbarino A; Rondena M; Martino E; Pinchera A; Faglia G
Horm Res; 1988; 29(2-3):121-3. PubMed ID: 2900192
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".
Gershengorn MC; Weintraub BD
J Clin Invest; 1975 Sep; 56(3):633-42. PubMed ID: 1159077
[TBL] [Abstract][Full Text] [Related]
6. Hyperthyroidism due to non-tumoural inappropriate TSH secretion. Effect of a long-acting somatostatin analogue (SMS 201-995).
Williams G; Kraenzlin M; Sandler L; Burrin J; Law A; Bloom S; Joplin GF
Acta Endocrinol (Copenh); 1986 Sep; 113(1):42-6. PubMed ID: 2876571
[TBL] [Abstract][Full Text] [Related]
7. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas.
Losa M; Giovanelli M; Persani L; Mortini P; Faglia G; Beck-Peccoz P
J Clin Endocrinol Metab; 1996 Aug; 81(8):3084-90. PubMed ID: 8768879
[TBL] [Abstract][Full Text] [Related]
8. [Inappropriate thyrotropin secretion. Part 1: tumoral (author's transl)].
Hamon P; Baulieu JL; Doumith R; Jambart S; Turpin G
Nouv Presse Med; 1981 Jun; 10(27):2285-8. PubMed ID: 6791127
[TBL] [Abstract][Full Text] [Related]
9. [Inadequate TSH secretion. Clinical features, diagnostic criteria, and therapeutic possibilities].
Caixàs A; Infiesta F; Balsells M; Rodríguez-Espinosa J; Schwarzstein D; Webb SM
Med Clin (Barc); 1994 May; 102(20):776-80. PubMed ID: 8041217
[TBL] [Abstract][Full Text] [Related]
10. Effects of thyroid hormones (T4,T3), bromocriptine and Triac on inappropriate TSH hypersecretion.
Salmela PI; Wide L; Juustila H; Ruokonen A
Clin Endocrinol (Oxf); 1988 May; 28(5):497-507. PubMed ID: 3214942
[TBL] [Abstract][Full Text] [Related]
11. Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients.
Wynne AG; Gharib H; Scheithauer BW; Davis DH; Freeman SL; Horvath E
Am J Med; 1992 Jan; 92(1):15-24. PubMed ID: 1346235
[TBL] [Abstract][Full Text] [Related]
12. Hyperthyroidism due to inappropriate secretion of thyroid-stimulating hormone: diagnosis and management.
Hermus A; Ross H; van Liessum P; Naber A; Smals A; Kloppenborg P
Neth J Med; 1991 Jun; 38(5-6):193-8. PubMed ID: 1922591
[TBL] [Abstract][Full Text] [Related]
13. [Hyperthyroidism caused by inadequate TSH secretion].
Zass R; Steindor U; Wendel U
Monatsschr Kinderheilkd; 1993 Feb; 141(2):100-2. PubMed ID: 7681522
[TBL] [Abstract][Full Text] [Related]
14. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.
Kunitake JM; Hartman N; Henson LC; Lieberman J; Williams DE; Wong M; Hershman JM
J Clin Endocrinol Metab; 1989 Aug; 69(2):461-6. PubMed ID: 2753985
[TBL] [Abstract][Full Text] [Related]
15. [Hyperthyroidism caused by a TSH producing pituitary adenoma].
Prasch F; Knosp SE; Steinbach R; Wogritsch S; Hurtl I; Greifeneder M; Holm C; Najemnik C; Dudczak R
Acta Med Austriaca; 1999; 26(1):32-6. PubMed ID: 10230475
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
Wu YY; Chang HY; Lin JD; Chen KW; Huang YY; Jung SM
J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
[TBL] [Abstract][Full Text] [Related]
17. Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity.
Beck-Peccoz P; Piscitelli G; Amr S; Ballabio M; Bassetti M; Giannattasio G; Spada A; Nissim M; Weintraub BD; Faglia G
J Clin Endocrinol Metab; 1986 Apr; 62(4):704-11. PubMed ID: 2419356
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin-releasing hormone and thyrotropin secretion.
Utiger RD
J Lab Clin Med; 1987 Mar; 109(3):327-35. PubMed ID: 3102657
[TBL] [Abstract][Full Text] [Related]
19. Hyperthyroidism caused by inappropriate thyrotropin hypersecretion: studies in patients with selective pituitary resistance to thyroid hormone.
Spanheimer RG; Bar RS; Hayford JC
Arch Intern Med; 1982 Jul; 142(7):1283-6. PubMed ID: 7092445
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients.
Gesundheit N; Petrick PA; Nissim M; Dahlberg PA; Doppman JL; Emerson CH; Braverman LE; Oldfield EH; Weintraub BD
Ann Intern Med; 1989 Nov; 111(10):827-35. PubMed ID: 2479309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
